Industry reports
Editor highlights

Pharmaceutical Industry Market Research Reports in Oceania Countries, April 2014

You might be interested in: drug, clinical trial, vaccine, more »

» View Public Reports

1-37 of about 1 300 reports

The Australian Pharmaceutical Business Brief

  • Industry report
  • April 2014
  • 8 pages
  • by Corporation

... To compare the expenditure of other chronic diseases, particularly chronic diseases that share many of the same risk factors such as ckd [14]. As a result, this investigation will determine and compare ...

  • Industries: Pathology
  • Countries: Australia

Company Report: Pathology in Australia for Year 2014

  • Company report
  • March 2014
  • 7 pages

... Are picked up and treated before permanent damage is done, ms clark said. If caught early, those affected may only need to make small lifestyle changes in order to prevent further loss, such as turning ...

  • Industries: Pathology
  • Countries: Australia

Drug and Medication Sector in The United States and Australia

  • Industry report
  • March 2014
  • 33 pages
  • by Corporation

... To serious infections and malignancy costs of current anti-tnf drug treatments are approximately $18-30k / year infliximab (remicade ) has been shown to have anti-map activity * hanauer at al ...

  • Industries: Drug and Medication
  • Countries: World, United States, Australia

The Australian Pharmaceutical Industry Brief

  • Industry report
  • March 2014
  • 18 pages
  • Industries: Pathology
  • Countries: Australia

Company Report: Pathology in The United States and Australia for Year 2014

  • Company report
  • March 2014
  • 3 pages

... cold. There is a theory that spontaneous remission in some cancer patients has potentially been due to infection of the common cold. The results from the phase ii study have been very impressive ...

  • Industries: Pathology
  • Countries: United States, Australia

Pharmaceutical Sector in New Zealand

  • Industry report
  • March 2014
  • 43 pages
  • Industries: Pathology
  • Countries: New Zealand

Company Report: Pathology in Australia for Year 2014

  • Company report
  • March 2014
  • 6 pages
  • Industries: Pathology
  • Countries: Australia

Company Report: Pathology in Australia for Year 2014

  • Company report
  • February 2014
  • 5 pages

... Are as a result of cancer, stroke, heart attack and coronary artery bypass grafts. However some trauma policies can cover more than 50 other critical illnesses. Life strategies can help you tailor ...

  • Industries: Pathology
  • Countries: Australia

Company Report: Drug and Medication in The United States, Australia and Singapore for Year 2014

  • Company report
  • February 2014
  • 11 pages
  • Industries: Drug and Medication
  • Countries: United States, Australia, Singapore

Company Report: Pharmacies and Drug Stores in Australia for Year 2014

  • Company report
  • February 2014
  • 3 pages
  • by Corporation

... Scheme in pharmacy in australia. Priceline was the only pharmacy retailer to rate in the top 10, ranked at number seven overall, among programs including those from qantas, coles and woolworths ...

  • Industries: Pharmacies and Drug Stores
  • Countries: Australia

Blackmores - Company Report for Year 2014

  • Company report
  • February 2014
  • 3 pages
  • by Corporation

... Retained dhl as the logistics provider for its direct distribution model until the end of 2016. The model had exceeded targets for supply of medicines to pharmacies, dhl supply chain life sciences ...

  • Industries: Drug and Medication
  • Countries: Australia

Company Report: Pathology in The United States, Australia and Canada for Year 2014

  • Company report
  • February 2014
  • 22 pages
  • Industries: Pathology
  • Countries: United States, Australia, Canada

Company Report: Pharmacies and Drug Stores in Australia for Year 2014

  • Company report
  • January 2014
  • 2 pages
  • by Corporation

... Medicines for sale in community pharmacies; whether to supply generic brands of s4 medicines; and how regulated health services and therapeutic goods are advertised. Just one click away from keeping up ...

  • Industries: Pharmacies and Drug Stores
  • Countries: Australia

Australian Pharmaceutical Industries Ltd. - Company Report for Year 2014

  • Company report
  • January 2014
  • 3 pages
  • Industries: Pharmacies and Drug Stores
  • Countries: Australia

Company Report: Drug and Medication in Australia, Europe and The United States for Year 2014

  • Company report
  • January 2014
  • 2 pages

... Of primary care drugs fell 10 percent to $3.44 Billion, mainly because of generic competition for viagra in europe and for the cholesterol fighter lipitor. Lipitor, the world's top-selling drug for nearly ...

  • Industries: Drug and Medication
  • Countries: Australia, Europe, United States

Perrigo Co. - Company Report for Year 2014

  • Company report
  • January 2014
  • 2 pages

... Commenced shipment of the product. Vanos cream 0.1% (fluocinonide cream 0.1%) Is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive ...

  • Industries: Drug and Medication
  • Countries: United States, World, Australia

Company Report: Pathology in Australia for Year 2014

  • Company report
  • January 2014
  • 2 pages
  • Industries: Pathology
  • Countries: Australia

Company Report: Pathology in Australia and The United States for Year 2014

  • Company report
  • January 2014
  • 2 pages

... Dollar also fell, closing the month down 2.0% At us$0.8748. The portfolio significantly outperformed its benchmark, thanks largely to its biggest position, australian liver cancer treatment company ...

  • Industries: Pathology
  • Countries: Australia, World, United States

Company Report: Pathology in The United States and Australia for Year 2014

  • Company report
  • January 2014
  • 2 pages
  • by Corporation
  • Industries: Pathology
  • Countries: United States, World, Australia

Company Report: Drug Delivery in Australia for Year 2014

  • Company report
  • January 2014
  • 15 pages

... As detailed in this presentation, our initial focus will be on vitamin d, where we expect to file for regulatory approval in the uk in 2014, followed soon thereafter with a focus on higher value drugs ...

  • Industries: Drug Delivery Technology
  • Countries: Australia

Company Report: Clinical Trial in The United States, Canada and Australia for Year 2013

  • Company report
  • December 2013
  • 4 pages
  • Industries: Drug Discovery and Development
  • Countries: United States, Canada, Australia

Company Report: Pharmaceutical in The United States, Australia and South Africa for Year 2013

  • Company report
  • December 2013
  • 5 pages

... Was $745k representing a decrease of $187k for the december quarter. The company expects the cash burn to be considerably lower over the next 6 months as work associated with the submission ...

  • Industries: Pharmaceutical
  • Countries: United States, Australia, South Africa

Drug Delivery Technology Industry in The United States and Australia

  • Industry report
  • December 2013
  • 7 pages
  • by Corporation

... The market has yet begun to recognize the value of the strategic position that we have created. We are poised to take a lead position in multiple, multi-billion dollar markets for injectable drug delivery ...

  • Industries: Drug Delivery Technology
  • Countries: United States, Australia

Progen Pharmaceuticals Ltd. - Company Report for Year 2013

  • Company report
  • December 2013
  • 20 pages
  • Industries: Pathology
  • Countries: Australia

Company Report: Drug Delivery Technology in Australia for Year 2013

  • Company report
  • December 2013
  • 5 pages

... Across products, drug delivery technologies and geographies and will pursue further business, product and brand acquisitions, in-licensing and out-licensing activity. Ongoing investment in research ...

  • Industries: Drug Delivery Technology
  • Countries: Australia

Company Report: Drug Discovery and Development in Australia for Year 2013

  • Company report
  • December 2013
  • 25 pages
  • Industries: Drug Discovery and Development
  • Countries: Australia

Alchemia Ltd. - Company Report for Year 2013

  • Company report
  • December 2013
  • 29 pages

... With cancer. Www.Alchemia.Com.Au drug discovery alchemia s vast technology utilises pyranose as a scaffold to generate novel molecules that are more diverse and complex in shape than the typical ...

  • Industries: Drug Discovery and Development
  • Countries: Australia

Company Report: Pathology in Australia for Year 2013

  • Company report
  • December 2013
  • 25 pages
  • Industries: Pathology
  • Countries: Australia

Company Report: Pharmacies and Drug Stores in Australia for Year 2013

  • Company report
  • December 2013
  • 20 pages
  • Industries: Pharmacies and Drug Stores
  • Countries: Australia

OrthoLogic Corp. - Company Report for Year 2013

  • Company report
  • December 2013
  • 4 pages
  • by Corporation
  • Industries: Drug Discovery and Development
  • Countries: United States, Australia, Canada

» Purchase Premium Reports (From $ 55 - $ 3 995)

About 500 reports
EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023

EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • February 2014
  • by Global Data

EpiCast Report: Major Depressive Disorder - Epidemiology Forecast to 2023 Summary Major depressive disorder (MDD), also known as clinical depression or major depression, is widely recognized as one of ...

Tuvalu Poisonings, Dalys

May 2013 $ 250

» Read our Company Profiles

1 Companies

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.